Alcon Plans PMA Submission In 2011 For Presbyopia/Toric Lens
This article was originally published in The Gray Sheet
Alcon plans to submit a PMA in 2011 for an AcrySof IQ ReSTOR Toric lens for presbyopia and astigmatism correction, the company reported during its July 27 second-quarter earnings call
You may also be interested in...
FDA’s ophthalmic devices advisory panel plans to meet on Nov. 14 to assess Alcon Laboratories’ PMA application for its AcrySof IQ Restor multifocal toric posterior chamber intraocular lens.
Alcon will launch a femtosecond laser system for cataract surgery in the fourth quarter after acquiring technology developer LenSx Lasers
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.